[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355947-105":59,"doc-detail-355947-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","sexual-orientation-and-gender-identity-based-disparities-in-colorectal-cervical-and-breast-cancer-screening-in-the-united-states","Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States","","Sexual orientation and gender identity (SOGI) minorities face disparities in health care access and quality, yet national evidence on adherence to recommended cancer screening is limited. This study evaluates associations between SOGI status and adherence to US Preventive Services Task Force recommendations for colorectal, cervical, and breast cancer. Adults from the 2018–2022 Behavioral Risk Factor Surveillance System were classified as sexual orientation minorities versus heterosexual and gender identity minorities versus cisgender, using survey-weighted Poisson regression to estimate adjusted prevalence ratios.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sexual-orientation-and-gender-identity-based-disparities-in-colorectal-cervical-and-breast-cancer-screening-in-the-united-states/355947/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sexual-orientation-and-gender-identity-based-disparities-in-colorectal-cervical-and-breast-cancer-screening-in-the-united-states/355947.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What was the study’s main objective?","Question",{"text":113,"@type":114},"To evaluate how sexual orientation and gender identity (SOGI) status is associated with adherence to USPSTF-recommended colorectal, cervical, and breast cancer screening.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were participants identified and categorized?",{"text":118,"@type":114},"Adults eligible for each screening type were identified from the 2018–2022 Behavioral Risk Factor Surveillance System and categorized as sexual orientation minorities vs heterosexual, and gender identity minorities vs cisgender.",{"name":120,"@type":111,"acceptedAnswer":121},"Which screening types showed lower adherence among SOGI minorities after adjustment?",{"text":122,"@type":114},"After adjustment, sexual orientation minorities had lower adherence to cervical and breast cancer screening compared with heterosexual women; gender identity minorities had substantially lower adherence to cervical and breast cancer screening, with no difference for colorectal screening.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355947,1790378359,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10. 1002/cncr.70462  \nORIGINAL ARTICLE  \nSexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States  \nLorenza Arena MD | Qaidar Alizai MD, MRCS | Abdulaziz Elemosho MD |  \nOdysseas P. Chatzipanagiotou MD  | Timothy M. Pawlik MD, MPH, MTS, MBA, PhD   \nDepartment of Surgery, The Ohio State University Wexner Medical Center and James Comprehensive Cancer Center, Columbus, Ohio, USA  \nCorrespondence  \nTimothy M. Pawlik, The Ohio State University, Wexner Medical Center, 395 W 12th Ave, Suite 670, Columbus, OH 43210-1267, USA. Email: [tim.pawlik@osumc.edu](tim.pawlik@osumc.edu)  \nAbstract  \nBackground: Sexual orientation and gender identity (SOGI) minorities experience disparities in health care access and quality of care, however national evidence regarding adherence to recommended cancer screening remains limited. This study aimed to evaluate associations between SOGI status and adherence to US Preventive Services Task Force-recommended colorectal, cervical, and breast cancer screening.  \nMethods: Adults eligible for colorectal (CRC; 45–74 years old), cervical (25–64 years old), or breast cancer (40–74 years old) screening were identified from the 2018–2022 Behavioral Risk Factor Surveillance System according to guidelineconcordant criteria. Respondents were categorized as sexual orientation minorities (SOM) versus heterosexual and as gender identity minorities (GIM) versus cisgender. Univariable results were reported as unweighted frequencies with survey-weighted proportions. Survey-weighted Poisson regression models were used to estimate adjusted prevalence ratios (aPRs) for screening adherence. Results: Among 663,924 unweighted screening-eligible respondents, weighted 1. 2%(n = 8108) identified as SOM and 0.4%(n = 2315) as GIM; 33. 5%(n = 223,065) were assigned male at birth and 67. 9%(n = 522,845) identified as White. After adjustment for covariates, SOM was associated with lower adherence to cervical (aPR, 0. 92; 95% CI, 0.87–0. 97) and breast cancer screening (aPR, 0.84; 95% CI, 0.77–0. 92) compared with heterosexual women. CRC screening adherence among SOM men was slightly higher (aPR, 1. 10; 95% CI, 1.00–1. 21). GIM status was associated with substantially lower adherence to cervical (aPR, 0. 58; 95% CI, 0.37–0. 90) and breast cancer screening (aPR, 0. 24; 95% CI, 0.08–0. 74) compared with cisgender respondents, with no difference in CRC screening (p > .05). Conclusions: Disparities in cervical and breast cancer screening persist among SOGI minorities. These findings underscore prevalent structural and systemic barriers in  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.  \n© 2026 The Author(s). Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.  \nCancer. 2026;e70462.  \n[https://doi.org/10.1002/cncr.70462](https://doi.org/10.1002/cncr.70462)  \nwi[leyonlinelibrary.com/journal/cncr](leyonlinelibrary.com/journal/cncr)  \n1 of 10  \npreventive cancer care and highlight the need for inclusive, culturally sensitive interventions to promote equitable screening access.  \nKEYWORDS  \ncancer screening, early detection of cancer, health care disparities, preventive health services, sexual and gender minorities  \nINTRODUCTION  \nDespite advances in diagnostics and treatment, nearly 10 million people die from cancer worldwide each year.1 In the United States, the CDC reported 1.8 million new cancer diagnoses in 2022. In 2023, deaths included 53,779 from colorectal cancer, 42,213 from female breast cancer, and 4162 from cervical cancer.2 Screening can substantially reduce cancer morbidity and mortality through early detection and timely treatment. The US Preventive Services Task Force (USPSTF) recommends routine screening for colorec","cbCaifAlywawZBce","https://ap.wps.com/l/cbCaifAlywawZBce","pdf",335757,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What was the study’s main objective?\",\"answer\":\"To evaluate how sexual orientation and gender identity (SOGI) status is associated with adherence to USPSTF-recommended colorectal, cervical, and breast cancer screening.\"},{\"question\":\"How were participants identified and categorized?\",\"answer\":\"Adults eligible for each screening type were identified from the 2018–2022 Behavioral Risk Factor Surveillance System and categorized as sexual orientation minorities vs heterosexual, and gender identity minorities vs cisgender.\"},{\"question\":\"Which screening types showed lower adherence among SOGI minorities after adjustment?\",\"answer\":\"After adjustment, sexual orientation minorities had lower adherence to cervical and breast cancer screening compared with heterosexual women; gender identity minorities had substantially lower adherence to cervical and breast cancer screening, with no difference for colorectal screening.\"}]","Sexual orientation and gender identity based disparities in colorectal, cervical, and breast cancer screening in the United States | PDF",1790121914,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6df859f311e14d57be20c51c7f36cd4d.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/219ef77d32c7945b7d2903c8b6acdb5b.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/133daa8657e434fe4ad62cb415238c25.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/878b5c0f74d3b5228b37f96d553127c1.webp",980,1287]